ID   TPP2_HUMAN              Reviewed;        1249 AA.
AC   P29144; Q5VZU8;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   07-APR-2021, entry version 189.
DE   RecName: Full=Tripeptidyl-peptidase 2;
DE            Short=TPP-2;
DE            EC=3.4.14.10;
DE   AltName: Full=Tripeptidyl aminopeptidase;
DE   AltName: Full=Tripeptidyl-peptidase II;
DE            Short=TPP-II;
GN   Name=TPP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-55, AND PROTEIN SEQUENCE OF 6-26.
RX   PubMed=1840501;
RA   Tomkinson B.;
RT   "Nucleotide sequence of cDNA covering the N-terminus of human tripeptidyl
RT   peptidase II.";
RL   Biomed. Biochim. Acta 50:727-729(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 56-1249.
RC   TISSUE=Lymphocyte;
RX   PubMed=1670990; DOI=10.1021/bi00215a025;
RA   Tomkinson B., Jonsson A.-K.;
RT   "Characterization of cDNA for human tripeptidyl peptidase II: the N-
RT   terminal part of the enzyme is similar to subtilisin.";
RL   Biochemistry 30:168-174(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-18 AND 1036-1046, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V., Quadroni M.;
RL   Submitted (JUL-2005) to UniProtKB.
RN   [7]
RP   PROTEIN SEQUENCE OF 13-26; 1099-1118 AND 440-450.
RX   PubMed=1691635; DOI=10.1042/bj2670149;
RA   Tomkinson B., Zetterqvist O.;
RT   "Immunological cross-reactivity between human tripeptidyl peptidase II and
RT   fibronectin.";
RL   Biochem. J. 267:149-154(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 441-450.
RX   PubMed=3313395; DOI=10.1073/pnas.84.21.7508;
RA   Tomkinson B., Wernstedt C., Hellman U., Zetterqvist O.;
RT   "Active site of tripeptidyl peptidase II from human erythrocytes is of the
RT   subtilisin type.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:7508-7512(1987).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19747897; DOI=10.1016/j.bbrc.2009.09.021;
RA   Preta G., de Klark R., Glas R.;
RT   "A role for nuclear translocation of tripeptidyl-peptidase II in reactive
RT   oxygen species-dependent DNA damage responses.";
RL   Biochem. Biophys. Res. Commun. 389:575-579(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-915, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Component of the proteolytic cascade acting downstream of the
CC       26S proteasome in the ubiquitin-proteasome pathway. May be able to
CC       complement the 26S proteasome function to some extent under conditions
CC       in which the latter is inhibited. Stimulates adipogenesis (By
CC       similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of an N-terminal tripeptide from a polypeptide.;
CC         EC=3.4.14.10; Evidence={ECO:0000255|PROSITE-ProRule:PRU10081,
CC         ECO:0000255|PROSITE-ProRule:PRU10082};
CC   -!- INTERACTION:
CC       P29144; Q08426: EHHADH; NbExp=5; IntAct=EBI-1044672, EBI-2339219;
CC       P29144; P06746: POLB; NbExp=8; IntAct=EBI-1044672, EBI-713836;
CC       P29144; Q96I34: PPP1R16A; NbExp=4; IntAct=EBI-1044672, EBI-710402;
CC       P29144; P29144: TPP2; NbExp=2; IntAct=EBI-1044672, EBI-1044672;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19747897}. Nucleus
CC       {ECO:0000269|PubMed:19747897}. Note=Translocates to the nucleus in
CC       responce to gamma-irradiation.
CC   -!- MISCELLANEOUS: The limitation of proteolytic products to tripeptides is
CC       achieved by tailoring the size of the substrate-binding cleft: the two
CC       negatively charged residues Glu-305 and Glu-331 that are blocking
CC       position P4 limit the number of residues that can be accommodated in
CC       the binding cleft and thus create a molecular ruler. At the same time,
CC       they orient substrates so that the tripeptides are removed exclusively
CC       from the N-terminus (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the peptidase S8 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL158063; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471085; EAX09059.1; -; Genomic_DNA.
DR   EMBL; BC039905; AAH39905.1; -; mRNA.
DR   EMBL; M73047; AAA36760.1; -; mRNA.
DR   EMBL; M55169; AAA63263.1; -; mRNA.
DR   CCDS; CCDS9502.1; -.
DR   PIR; S54376; S54376.
DR   RefSeq; NP_001317517.1; NM_001330588.1.
DR   RefSeq; NP_003282.2; NM_003291.3.
DR   BioGRID; 113027; 50.
DR   DIP; DIP-50761N; -.
DR   IntAct; P29144; 27.
DR   MINT; P29144; -.
DR   STRING; 9606.ENSP00000365233; -.
DR   BindingDB; P29144; -.
DR   ChEMBL; CHEMBL6156; -.
DR   GuidetoPHARMACOLOGY; 2423; -.
DR   MEROPS; S08.A56; -.
DR   iPTMnet; P29144; -.
DR   MetOSite; P29144; -.
DR   PhosphoSitePlus; P29144; -.
DR   SwissPalm; P29144; -.
DR   BioMuta; TPP2; -.
DR   DMDM; 34223721; -.
DR   EPD; P29144; -.
DR   jPOST; P29144; -.
DR   MassIVE; P29144; -.
DR   MaxQB; P29144; -.
DR   PaxDb; P29144; -.
DR   PeptideAtlas; P29144; -.
DR   PRIDE; P29144; -.
DR   ProteomicsDB; 54528; -.
DR   Antibodypedia; 11138; 122 antibodies.
DR   Ensembl; ENST00000376065; ENSP00000365233; ENSG00000134900.
DR   GeneID; 7174; -.
DR   KEGG; hsa:7174; -.
DR   UCSC; uc001vpi.5; human.
DR   CTD; 7174; -.
DR   DisGeNET; 7174; -.
DR   GeneCards; TPP2; -.
DR   HGNC; HGNC:12016; TPP2.
DR   HPA; ENSG00000134900; Low tissue specificity.
DR   MalaCards; TPP2; -.
DR   MIM; 190470; gene.
DR   neXtProt; NX_P29144; -.
DR   OpenTargets; ENSG00000134900; -.
DR   Orphanet; 444463; Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome.
DR   PharmGKB; PA36695; -.
DR   VEuPathDB; HostDB:ENSG00000134900.11; -.
DR   eggNOG; KOG1114; Eukaryota.
DR   GeneTree; ENSGT00390000014623; -.
DR   HOGENOM; CLU_003084_1_0_1; -.
DR   InParanoid; P29144; -.
DR   OrthoDB; 156304at2759; -.
DR   PhylomeDB; P29144; -.
DR   TreeFam; TF105647; -.
DR   BRENDA; 3.4.14.10; 2681.
DR   PathwayCommons; P29144; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P29144; -.
DR   BioGRID-ORCS; 7174; 224 hits in 995 CRISPR screens.
DR   ChiTaRS; TPP2; human.
DR   GeneWiki; Tripeptidyl_peptidase_II; -.
DR   GenomeRNAi; 7174; -.
DR   Pharos; P29144; Tchem.
DR   PRO; PR:P29144; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; P29144; protein.
DR   Bgee; ENSG00000134900; Expressed in testis and 238 other tissues.
DR   ExpressionAtlas; P29144; baseline and differential.
DR   Genevisible; P29144; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004177; F:aminopeptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004175; F:endopeptidase activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0008240; F:tripeptidyl-peptidase activity; IBA:GO_Central.
DR   GO; GO:0000209; P:protein polyubiquitination; TAS:Reactome.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   CDD; cd04857; Peptidases_S8_Tripeptidyl_Aminopeptidase_II; 1.
DR   Gene3D; 3.40.50.200; -; 1.
DR   InterPro; IPR000209; Peptidase_S8/S53_dom.
DR   InterPro; IPR036852; Peptidase_S8/S53_dom_sf.
DR   InterPro; IPR022398; Peptidase_S8_His-AS.
DR   InterPro; IPR023828; Peptidase_S8_Ser-AS.
DR   InterPro; IPR015500; Peptidase_S8_subtilisin-rel.
DR   InterPro; IPR022229; Peptidase_S8A_TPPII.
DR   InterPro; IPR034051; TPP_II_domain.
DR   Pfam; PF00082; Peptidase_S8; 1.
DR   Pfam; PF12580; TPPII; 1.
DR   PRINTS; PR00723; SUBTILISIN.
DR   SUPFAM; SSF52743; SSF52743; 1.
DR   PROSITE; PS51892; SUBTILASE; 1.
DR   PROSITE; PS00137; SUBTILASE_HIS; 1.
DR   PROSITE; PS00138; SUBTILASE_SER; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminopeptidase; Cytoplasm; Direct protein sequencing;
KW   Hydrolase; Nucleus; Phosphoprotein; Protease; Reference proteome;
KW   Serine protease.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.6"
FT   CHAIN           2..1249
FT                   /note="Tripeptidyl-peptidase 2"
FT                   /id="PRO_0000076422"
FT   DOMAIN          9..508
FT                   /note="Peptidase S8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        44
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        264
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   ACT_SITE        449
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01240"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.6"
FT   MOD_RES         401
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64514"
FT   MOD_RES         915
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   CONFLICT        252
FT                   /note="G -> R (in Ref. 5; AAA36760)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1249 AA;  138350 MW;  A26A6249DBF7F3DD CRC64;
     MATAATEEPF PFHGLLPKKE TGAASFLCRY PEYDGRGVLI AVLDTGVDPG APGMQVTTDG
     KPKIVDIIDT TGSGDVNTAT EVEPKDGEIV GLSGRVLKIP ASWTNPSGKY HIGIKNGYDF
     YPKALKERIQ KERKEKIWDP VHRVALAEAC RKQEEFDVAN NGSSQANKLI KEELQSQVEL
     LNSFEKKYSD PGPVYDCLVW HDGEVWRACI DSNEDGDLSK STVLRNYKEA QEYGSFGTAE
     MLNYSVNIYD DGNLLSIVTS GGAHGTHVAS IAAGHFPEEP ERNGVAPGAQ ILSIKIGDTR
     LSTMETGTGL IRAMIEVINH KCDLVNYSYG EATHWPNSGR ICEVINEAVW KHNIIYVSSA
     GNNGPCLSTV GCPGGTTSSV IGVGAYVSPD MMVAEYSLRE KLPANQYTWS SRGPSADGAL
     GVSISAPGGA IASVPNWTLR GTQLMNGTSM SSPNACGGIA LILSGLKANN IDYTVHSVRR
     ALENTAVKAD NIEVFAQGHG IIQVDKAYDY LVQNTSFANK LGFTVTVGNN RGIYLRDPVQ
     VAAPSDHGVG IEPVFPENTE NSEKISLQLH LALTSNSSWV QCPSHLELMN QCRHINIRVD
     PRGLREGLHY TEVCGYDIAS PNAGPLFRVP ITAVIAAKVN ESSHYDLAFT DVHFKPGQIR
     RHFIEVPEGA TWAEVTVCSC SSEVSAKFVL HAVQLVKQRA YRSHEFYKFC SLPEKGTLTE
     AFPVLGGKAI EFCIARWWAS LSDVNIDYTI SFHGIVCTAP QLNIHASEGI NRFDVQSSLK
     YEDLAPCITL KNWVQTLRPV SAKTKPLGSR DVLPNNRQLY EMVLTYNFHQ PKSGEVTPSC
     PLLCELLYES EFDSQLWIIF DQNKRQMGSG DAYPHQYSLK LEKGDYTIRL QIRHEQISDL
     ERLKDLPFIV SHRLSNTLSL DIHENHSFAL LGKKKSSNLT LPPKYNQPFF VTSLPDDKIP
     KGAGPGCYLA GSLTLSKTEL GKKADVIPVH YYLIPPPTKT KNGSKDKEKD SEKEKDLKEE
     FTEALRDLKI QWMTKLDSSD IYNELKETYP NYLPLYVARL HQLDAEKERM KRLNEIVDAA
     NAVISHIDQT ALAVYIAMKT DPRPDAATIK NDMDKQKSTL VDALCRKGCA LADHLLHTQA
     QDGAISTDAE GKEEEGESPL DSLAETFWET TKWTDLFDNK VLTFAYKHAL VNKMYGRGLK
     FATKLVEEKP TKENWKNCIQ LMKLLGWTHC ASFTENWLPI MYPPDYCVF
//
